BioTelemetry (BEAT) Tops Q3 EPS by 3c

BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $53.1 million versus the consensus estimate of $52.92 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• C.H. Robinson acquires DeSpir Logistics for $75 million